Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Global Neurotrophic Keratitis Market Outlook 2023-2036" report has been added to ResearchAndMarkets.com's offering.
The global neurotrophic keratitis market is anticipated to grow at a CAGR of 17.07% over the forecast period, 2024-2036. The increasing prevalence and incidences of neurotrophic keratitis, upsurge the demand for novel therapies & treatment, advancement in neurotrophic keratitis treatment are the few factors that are driving the market growth. The market is estimated to garner a revenue of USD 1.45 billion by the end of 2036, up from a revenue of USD 192.54 million in the year 2023.
The global neurotrophic keratitis market is segmented by treatment type, application, and by region. On the basis of treatment type, the market is segmented into surgical intervention and drugs. By the end of 2036, the drugs segment is anticipated to garner the largest revenue of around USD 1.06 billion, up from a revenue of nearly USD 138.69 million in the year 2023.
The market for neurotrophic keratitis is defined by a variety of medications created to handle the particular difficulties this illness presents. Bacterial invasion is more likely in situations where the cornea is damaged, such as chronic epithelial abnormalities. Antibiotics aid in the management and prevention of bacterial infections that may worsen the illness which is responsible for the growth of this segment.
On the basis of region, the global neurotrophic keratitis market is classified into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. By the end of 2036, it is predicted that the North American market will have the highest revenue of around USD 458.34 million out of all the markets in the other areas. Moreover, in the year 2023, the regional market generated a revenue of nearly USD 60.07 million. To improve therapeutic efficacy and diagnostic accuracy, medical practitioners in the area are taking a multidisciplinary approach, merging their experience in neurology, infectious diseases, and ophthalmology. This cooperative approach facilitates the development of focused treatment methods and adds to a more thorough understanding of neurotrophic keratitis.
Some of the prominent industry leaders in the global neurotrophic keratitis market that are included in the report are Oyster Point Pharma, Neuroptica, Recordati Rare Diseases, KALA BIO, ReGenTree, BRIM Biotechnology, Bausch + Lomb, Oculis and HLB Therapeutics.
Key Topics Covered:
1. An Introduction to the Research Study
1.1. Preface
1.2. Market Taxonomy
1.3. Definition of the Market and the Segments
1.4. Acronyms and Assumptions
2. The Research Procedure
3. Recommendation by Analyst for C-level Executives
4. An Abstract of the Report
5. Evaluation of Market Fluctuations and Outlook
5.1. Market Growth Drivers
5.2. Market Growth Deflation
5.3. Market Trends
5.3.1. Manufacturer Based
5.3.2. End-User Based
6. Fundamental Market Prospects
6.1. Strategic Competitive Opportunities
6.2. Geographic Opportunities
6.3. Application Centric Opportunities
7. Regulatory & Standards Landscape
8. Economic Outlook: Japan
9. Recent Trends/ Developments in Global Neurotrophic Keratitis Market
10. Technology Transition & Adoption Analysis
11. Industry Value Chain Analysis
12. Industry Risk Analysis
13. Pipeline Analysis
14. Market Unmet Needs Analysis
15. Industry Growth Outlook
16. Global Neurotrophic Keratitis Market Outlook
16.1. Market Overview
16.2. Market Value (USD Million) Current and Future Projections, 2023-2036
16.3. Market Increment $ Opportunity Assessment, 2023-2036
16.4. Year-on-Year (YoY) Growth Trend Analysis
16.5. By Treatment Type
16.5.1. Segmentation by Drugs Market Value USD Million) Current and Future Projections, 2023-2036
16.5.1.1. Artificial Tears Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.1.2. Recombinant Human Nerve Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.1.3. Growth Factors Eye Drops Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.1.4. Antibiotics Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.1.5. Bandage Contact Lens Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.1.6. Others Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.2. Segmentation by Surgical Intervention Market Value USD Million) Current and Future Projections, 2023-2036
16.5.2.1. Tarsal Plate Suture Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.2.2. Amniotic Membrane Transplant Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.2.3. Others Market Value (USD Million) Current and Future Projections, 2023-2036
16.6. By Application
16.6.1. Stage I Market Value (USD Million) Current and Future Projections, 2023-2036
16.6.2. Stage II Market Value (USD Million) Current and Future Projections, 2023-2036
16.6.3. Stage III Market Value (USD Million) Current and Future Projections, 2023-2036
16.7. By Geography
17. Cross Analysis of Treatment Type w.r.to. Application (USD Million), 2023-2036
18. North America Neurotrophic Keratitis Market Outlook
19. Europe Neurotrophic Keratitis Market Outlook
20. Asia Pacific Excluding Japan (APEJ) Neurotrophic Keratitis Market Outlook
21. Japan Neurotrophic Keratitis Market Outlook
22. Latin America Neurotrophic Keratitis Market Outlook
23. Middle East & Africa Neurotrophic Keratitis Market Outlook
24. Competitive Model: A Detailed Inside View for Investors
24.1. Company Market Share
24.2. Business Profile of Key Enterprises
- Dompe
- Oyster Point Pharma, Inc.
- Neuroptica, Inc.
- Recordati Rare Diseases
- KALA BIO
- ReGenTree, LLC
- BRIM Biotechnology, Inc.
- Bausch + Lomb Incorporated
- Oculis
- HLB Therapeutics
For more information about this report visit https://www.researchandmarkets.com/r/xapbhr
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
